Additional information
Gummy Liquid
1797008-41-3
ACI-021714
C19H28ClN3O3
381.9
Ambient
2-8°C
Chemotherapy
Pharmaceutical Impurity Standards
4-{5-[(2-Chloro-ethyl)-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazole-2-yl}-bytyric acid isorpopyl ester (HP-1 Ester Impurity)
4-{5-[(2-Chloro-ethyl)-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazole-2-yl}-bytyric acid isorpopyl ester (HP-1 Ester Impurity)
1-Methylethyl 5-[(2-chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoate





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)